Home > Insider Trading > Filing (0001209191-21-018532)

Filing Details

Accession Number:: 0001209191-21-018532
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-08 16:12:10
Reporting Period:: 2021-03-04

Accepted Time:: 2021-03-08 16:12:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1754068	Allovir Inc.	ALVR	Biological Products, (No Disgnostic Substances) (2836)	831971007

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1818068	Malcolm Brenner	C/O Allovir, Inc. 139 Main Street, Suite 500 Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-03-04	15,961	$34.67	900,391	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-04	13,876	$35.46	886,515	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-04	8,814	$36.58	877,701	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-04	10,947	$37.41	866,754	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-05	23,660	$30.39	843,094	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-05	15,289	$31.27	827,805	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-05	6,141	$32.19	821,664	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-05	2,300	$33.31	819,364	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-05	701	$34.40	818,663	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	30,197	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.06 to $35.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.06 to $36.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.06 to $37.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.07 to $37.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.90 to $30.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.90 to $31.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.90 to $32.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.90 to $33.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.01 to $34.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.